RESUMEN
Objective To investigate the changes of serum creatine kinase (CK),creatine kinase isoenzyme (CK-MB),cardiac troponin I(cTnI)and electrocardiogram (ECG) before and after the treatment of pneumo-nia in children.Methods From December 2014 to December 2016,95 children with pneumonia were selected as the study group,and 48 healthy subjects who underwent the healthy assessment from December 2014 to January 2016 were selected as the control group.All children with pneumonia were treated after admission.2 mL of venous blood were collected from each research subject after the admission and patients in study group after treatment,serum was seperated,and levels of CK,CK-MB,cTnI were measured and the ECG record was conducted.Results The serum levels of CK,CK-MB and cTnI in the study group were higher than those in the control group (P<0.05);the incidences of ST segment elevation or depression,atrial premature beat,ven-tricular premature beat,sinus tachycardia and sinus bradycardia in the study group were higher than those in the control group,and the differences were statistically significant (P<0.05);the serum levels of CK,CK-MB and cTnI in the study group were lower than those before treatment,and the difference was statistically signif-icant (P<0.05);the incidences of atrial premature beat,ventricular premature beat,sinus tachycardia and si-nus bradycardia in the study group after treatment were lower than those before treatment,and the difference was statistically significant (P<0.05);the incidence of ST segment elevation or depression after treatment in the study group was lower than that before treatment,and there was no significant difference (P>0.05).Con-clusion The serum levels of CK,CK-MB,cTnI and ECG were obviously abnormal in children with pneumoni-a.After treatment,serum CK,CK-MB and cTnI levels can be reduced and ECG abnormalities can be ameliora-ted.
RESUMEN
Objective To understand the epidemiological characteristics of child pneumonia mycoplasma infection to provide a forceful basis for its clinical diagnosis and treatment.Methods A total of 6 823 children outpatients and inpatients with pneumonia in this hospital from January 2015 to December 2016 were performed the serum Mycoplasma pneumoniae antibody detection by using the passive agglutination method.Results (1) Among 6 823 children cases,Mycoplasma pneumonia antibody positive detection was in 1 843 cases,the positive rate was 27,01 ％,among them,the infection rate of female was higher than that of male (32.68％ vs.23.21％,P＜0.01).(2) Mycoplasma pneumoniae antibody detection rates in ＜1 year old,1-＜3 years old,3-＜6 years old,6-14 years old were 5.41％,28.01％,40.34％ and 43.81％ respectively (P＜0.01),the total detection rate in ≥ 3 years old group was higher than that in ＜3 years old group (P＜0.01).Conclusion Mycoplasma pneumoniae infection rate is higher among children with respiratory tract infection,the incidence rate in school-age children is lower.The autumnand winter seasons are prevalent.
RESUMEN
Objective To assess the academic level of randomized controlled trial abstracts in papers on budesonid adjuvant therapy for children pneumonia and analyze its influencing factors. Methods The randomized controlled tri-al abstracts in papers on budesonid adjuvant therapy for children pneumonia were assessed according to the CON-SORT 2010 Statement and were statistically analyzed using the RevMan 5 . 3 . Results The items with a low reporting rate of the randomized controlled trial abstracts in the 282 papers included in this paper were "title judged as ran-dom","communication author","randomized","blind method","randomized grouping cases","fund-suppor-ted". Hierarchical analysis showed that the number of words in abstracts played an important role in affecting the reported items. Conclusion The academic level of randomized controlled trial abstracts in papers on budesonid adju-vant therapy for children pneumonia is significantly different from that of the abstracts in clinical papers according to the CONSORT 2010 Statement. Researchers should thus use the CONSORT 2010 Statement-defined items in writing their papers in order to improve the academic level and readability of their abstracts.
RESUMEN
Objective To systematically evaluate the application effect of clinical pathways in children pneumonia patients by u-sing the system analysis .Methods Published RCT in children pneumonia patients were searched and screened in CNKI ,VIP ,CBM-disc and Wanfang datebase under present standards .The quality of the included studies were evaluated and statistical analyzed by RevMan5 .0 software .Results Total 17 literatures including 2 717 cases were eligible to the criteria (1 359 in clinical pathways group and 1 358 in control group)altogether .The system analysis showed there were significant difference between the clinical path-way group and the traditional treatment group in grasp of health knowledge [RR=1 .30 ,95% CI(1 .17 -1 .44) ,P<0 .01] ,rate of patients ,satisfaction[RR=1 .17 ,95% CI(1 .13 -1 .21) ,P<0 .01] ,length of hospital stay [WMD= -2 .90 ,95% CI(-3 .93 - -1 .86) ,P<0 .01] ,hospitalization expenses[WMD= -620 .02 ,95% CI(-838 .99 - -401 .04) ,P<0 .01] ,the body temperature to restore normal time[WMD= -1 .67 ,95% CI(-2 .10- -1 .23) ,P<0 .01] ,lung sound disappear time[WMD= -1 .80 ,95% CI(-2 .15- -1 .45) ,P<0 .01] .Conclusion Clinical pathways is superior compared with the traditional treatment for children pneumo-nia patients ,be worthy of spread in clinical .
RESUMEN
OBJECTIVE:To compare the pharmacoeconomic efficacies of 5 drug therapeutic regimens for children pneumonia.METHODS:Using retrospective study and cost-effectiveness analysis to compare the pharmacoeconomic efficacies among the following 5 regimens in treating children pneumonia:amoxicillin sodium/clavulanate potassium(Group A),cefotaxime sodium(Group B),cefoperazone sodium/sulbactam sodium(Group C),cefuroxime sodium(Group D),and azithromycin(Group E).RESULTS:The effective rates of the 5 groups(A,B,C,D and E) were 80.43%,76.09%,65.12%,77.27%,and 91.30%,respectively,and the cost-effectiveness ratios were 1 595.06,1 225.38,1 669.69,1 284.83,and 697.84,respectively.CONCLU-SION:The regimen of azithromycin(group E) is the optimal one among the 5 groups for children pnemonia.
RESUMEN
0.05),the costs were 915.70 and 1 036.80 yuan(P
RESUMEN
[Objective]To observe the relationship between children pneumonia signs and types.[Method] Make analysis on TCM syndromes of 190 cases of children pneumonia,observe the difference among all syndromes.[Result] The syndrome of phlegm heat blocking lung is featured with fever,heavy cough,much sputum,red tongue,yellow greasy moss,slippery and quick pulse/purple and stagnant finger mark;the syndrome of wind heat with fever,heavy cough,snuffle and runny nose,red tongue,thin and yellow moss,shallow and quick pulse/ purple and shallow finger mark;qi deficiency of lung and spleen with impotent cough,much sputum,pale face,light tongue,white and greasy moss,thin pulse/light red or stagnant finger mark.[Conclusion] The fever,cough sound,sputum spitting or phlegm block degree,nose symptoms,face color,tongue and pulse(finger mark) have much influence on types classification,being the key indexes in differentiation of signs.
RESUMEN
0.05),but the total expenses and antibiotic cost of the medical treatment in group B were obviously lower than those in group A(P
RESUMEN
0.05);The costs of the two were926.40yuan and1370.30yuan respectively(P